Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACIFIC-AF Japan: Asundexian vs Apixaban in Atrial Fibrillation
jRCT2080225110Phase 2Completed
- Start
- Mar 2020
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of asundexian in Atrial fibrillation (AFib) (3 arms). Primary endpoint: Bleeding events. Started Mar 2020; status: completed.
02
Drugs
asundexian
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on jRCT2080225110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225110.